Kawasaki disease, myocardial infarction and coronary artery revascularization

Canadian Journal of Cardiology

Volumn 21, Issue 7, 2005, Pages 601-604

  Wong, Derek ^a   Harder, Joyce ^b   Jadavji, Taj ^a,b  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Coronary artery bypass grafting; Kawasaki disease; Myocardial infarction; Percutaneous transluminal coronary angioplasty; Stenosis

Indexed keywords

ACETYLSALICYLIC ACID; CAPTOPRIL; GLYCERYL TRINITRATE; IMMUNOGLOBULIN; INOTROPIC AGENT; METHYLPREDNISOLONE;

ANAMNESIS; ARTICLE; CASE REPORT; CHILD; CLINICAL PROTOCOL; CORONARY ARTERY ANEURYSM; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFANT; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE PERIOD; TREATMENT OUTCOME;

ALBERTA; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; RISK ASSESSMENT; SAMPLING STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 21644477082     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Burns JC, Kushner HI, Bastian JF, et al. Kawasaki disease: A brief history. Pediatrics 2000;106:E27.
2. Laupland KB, Dele Davies H. Epidemiology, etiology, and management of Kawasaki disease: State of the art. Pediatr Cardiol 1999;20:177-83.
3. Zhang T, Yanagawa H, Oki I, et al. Factors related to cardiac sequelae of Kawasaki disease. Eur J Pediatr 1999;158:694-7.
4. Nakamura Y, Yanagawa H, Kato H, Kawasaki T. Mortality rates for patients with a history of Kawasaki disease in Japan. Kawasaki Disease Follow-Up Group. J Pediatr 1996;128:75-81.
5. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324;1633-9.
6. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85.
7. Nakamura Y, Yanagawa H, Harada K, Kato H, Kawasaki T. Mortality among persons with a history of Kawasaki disease in Japan: The fifth look. Arch Pediatr Adolesc Med 2002;156:162-5.
8. Silva AA, Maeno Y, Hashmi A, Smallhorn JF, Silverman ED, McCrindle BW. Cardiovascular risk factors after Kawasaki disease: A case-control study. J Pediatr 2001;138:400-5.
9. Nakamura Y, Yanagawa H, Ojima T, Kawasaki T, Kato H. Cardiac sequelae of Kawasaki disease among recurrent cases. Arch Dis Child 1998;78:163-5.
10. Nakano H, Saito A, Ueda K, Nojima K. Clinical characteristics of myocardial infarction following Kawasaki disease: Report of 11 cases. J Pediatr 1986;108:198-203.
11. Kato H, Ichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease: Clinical analyses in 195 cases. J Pediatr 1986;108:923-7.
12. Davies HD, Kirk V, Jadavji T, Kotzin BL. Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male. Pediatr Infect Dis J 1996;15:1136-8.
13. Brenner JL, Jadavji T, Pinto A, Trevenen C, Patton D. Severe Kawasaki disease in infants: Two fatal cases. Can J Cardiol 2000;16:1017-23. (Erratum in 2000;16:1206).
14. Ogawa S, Fukazawa R, Ohkubo T, et al. Silent myocardial ischemia in Kawasaki disease: Evaluation of percutaneous transluminal coronary angioplasty by dobutamine stress testing. Circulation 1997;96:3384-9.
15. Kitamura S, Kameda Y, Seki T, et al. Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study. J Thorac Cardiovasc Surg 1994;107:663-73.
16. Kitamura S, Kawashima Y, Fujita T, Mori T, Oyama C. Aortocoronary bypass grafting in a child with coronary artery obstruction due to mucocutaneous lymphnode syndrome: Report of a case. Circulation 1976;53:1035-40.
17. Kitamura S, Kawachi K, Harima R, Sakakibara T, Hirose H, Kawashima Y. Surgery for coronary heart disease due to mucocutaneous lymph node syndrome (Kawasaki disease). Report of 6 patients. Am J Cardiol 1983;51:444-8.
18. Suma K, Takeuchi Y, Shiroma K, et al. Early and late postoperative studies in coronary arterial lesions resulting from Kawasaki's disease in children. J Thorac Cardiovasc Surg 1982;84:224-9.
19. Sandiford FM, Vargo TA, Shih JY, Pelargonio S, McNamara DG. Successful triple coronary artery bypass in a child with multiple coronary aneurysms due to Kawasaki's disease. J Thorac Cardiovasc Surg 1980;79:283-7.
20. Myers JL, Gleason MM, Cyran SE, Baylen BG. Surgical management of coronary insufficiency in a child with Kawasaki's disease: Use of bilateral internal mammary arteries. Ann Thorac Surg 1988;46:459-61.
21. Gotteiner N, Mavroudis C, Backer CL, et al. Coronary artery bypass grafting for Kawasaki disease. Pediatr Cardiol 2002;23:62-7.
22. Sobczyk W, Austin E, Elbl F, Solinger R, Kirsch L, Rees A. Successful double bypass grafting in a child with coronary artery obstruction due to Kawasaki disease. South Med J 1996;89:420-1.
23. Sugimura T, Yokoi H, Sato N, et al. Interventional treatment for children with severe coronary artery stenosis with calcification after long-term Kawasaki disease. Circulation 1997;96:3928-33.
24. Matsui H, Yasui S, Saito S. Complications of percutaneous transluminal coronary rotational ablation in Kawasaki disease. Pediatr Cardiol 2000;21:500-1.
25. Hijazi ZM, Coronary arterial stenosis after Kawasaki disease: Role of catheter intervention. Catheter Cardiovasc Interv 1999;46:337.
26. Akagi T, Ogawa S, Ino T, et al. Catheter interventional treatment in Kawasaki disease: A report from the Japanese Pediatric Interventional Cardiology Investigation Group. J Pediatr 2000;137:181-6.
27. Ueno T, Kai H, Ikeda H, Ichiki K, Hashino T, Imaizumi T. Coronary stent deployment in a young adult with Kawasaki disease and recurrent myocardial infarction. Clin Cardiol 1999;22:147-9.
28. Hashmi A, Lazzam C, McCrindle BW, Benson LN. Stenting of coronary artery stenosis in Kawasaki disease. Catheter Cardiovasc Interv 1999;46:333-6.
29. Ino T, Akimoto K, Ohkubo M, et al. Application of percutaneous transluminal coronary angioplasty to coronary arterial stenosis in Kawasaki disease. Circulation 1996;93:1709-15.
30. Heaton P, Wilson N. Fatal Kawasaki disease caused by early occlusive coronary artery disease. Arch Dis Child 2002;87:145-6.
31. Burke AP, Virmani R, Perry LW, Li L, King TM, Smialek J. Fatal Kawasaki disease with coronary arteritis and no coronary aneurysms. Pediatrics 1998;101:108-12.
32. Checchia PA, Pahl E, Shaddy RE, Shulman ST. Cardiac transplantation for Kawasaki disease. Pediatrics 1997;100:695-9.
33. Furuyama H, Odagawa Y, Katoh C, et al. Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 2003;142:149-54.
34. Deng YB, Li TL, Xiang HJ, Chang Q, Li CL. Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J 2003;22:34-9.
35. Mitani Y, Okuda Y, Shimpo H, et al. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation 1997;96:454-61.
36. Mitani Y. Coronary endothelial dysfunction after Kawasaki disease. J Am Coll Cardiol 2000;35:821-3.
37. Sugimura T, Kato H, Inoue O, et al. Intravascular ultrasound of coronary arteries in children. Assessment of the wall morphology and the lumen after Kawasaki disease. Circulation 1994;89:258-65.